2018

Session 8A: Latency

Session 8A Latency 10:30 AM – 12:00 PMSession Chairs: Jennifer Totonchy & Maria Masucci EBV Persistence without its EBNA3A and 3C Oncogenes in vivo Anita Murer Oral Talk #62 EBV Persistence without its EBNA3A and 3C Oncogenes in vivo Anita Murer1, Donal McHugh1, Nicole Caduff1, Jens Kalchschmidt2, Mario Barros3, Andrea Zbinden4, Riccarda Capaul4, Gerald Niedobitek3, […]

Session 8A: Latency Read More »

Session 7: Non-Coding RNAs

Session Chairs: Scott Tibbetts & Erik Flemington Oral Talk #54 Misprocessing of Cellular Noncoding RNAs as a Pathway for Cell-Intrinsic Immune Activation Yang Zhao1, Xiang Ye1, William Dunker1, Yu Song1, John Karijolich1 1Vanderbilt University School of Medicine The RIG-I like receptors (RLRs) RIG-I and MDA5 are cytosolic RNA helicases best characterized as restriction factors for

Session 7: Non-Coding RNAs Read More »

Session 6: Co-Infections

Session Chairs: Denise Whitby & Christian Münz Oral Talk #50 Malaria as a Risk Factor for Early Age of KSHV Infection in a Cohort of Children in Western Kenya Rosemary Rochford1, Katherine Sabourin1, Ibrahim Daud3, Peter O. Sumba3, Nazzarrena Labo2, Wendell Miley2, Denise Whitby21University of Colorado, 2Frederick National Laboratory for Cancer Research, 3Kenya Medical Research

Session 6: Co-Infections Read More »

Keynote Address III: Bettina Kempkes (13:00)

1:00 PM Keynote Address III Bettina Kempkes Bettina Kempkes studied biology and graduated from the Albert-LudwigUniversity Freiburg in 1986. She received her PhD at the Max-PlanckInstitute of Immunobiology in Freiburg for her work on the T cell receptorrepertoire of hapten-specific T cells in 1989. Between 1989 and 1994 sheworked as a postdoctoral research fellow at

Keynote Address III: Bettina Kempkes (13:00) Read More »

Session 5B: Epidemiology

Session Chairs: Charles Wood & Alan Chiang  (Play Circle)Newly Derived endemic Burkitt Lymphoma Cell Lines from Kenyan Patients and the Makings of an Avatar Mouse Model Ann M. Moormann Oral Talk #43 Newly Derived Endemic Burkitt Lymphoma Cell Lines from Kenyan Patients and the Makings of an Avatar Mouse Model Ann M. Moormann1, Priya Saikumar

Session 5B: Epidemiology Read More »

Session 4: Lytic Cycle II

Session Chairs: Fanxiu Zhu & Richard Longnecker Oral Talk #29 The EBV Glycoprotein BDLF2 is Essential for the Infection of Stratified Epithelium Ian Hayman1, Joshua Walston1, Mindy Gore2, Lindsey Hutt-Fletcher2, Clare E. Sample1 1Department of Microbiology and Immunology, The Pennsylvania State University College of Medicine, 2Department of Microbiology and Immunology, Louisiana State University Health Sciences

Session 4: Lytic Cycle II Read More »

Session 2A | 2B: Lytic Cycle I | Therapeutics & Vaccines

Lytic Cycle I : Linda van Dyk and Mei-Ru Chen Oral Talk #8 Continuous DNA Replication Is Required for Late Gene Transcription and Maintenance of Replication Compartments in Gammaherpesviruses Dajiang Li1, Wenmin Fu1, Sankar Swaminathan1,2 1Division of Infectious Diseases, Department of Medicine, University of Utah School of Medicine, 2George E. Wahlen Department of Veterans Affairs Medical

Session 2A | 2B: Lytic Cycle I | Therapeutics & Vaccines Read More »

Session 1: Gene Expression/Epigenetics

Session Chairs: Ke Lan and Wolfgang Hammerschmidt [9:00 AM – 10:30 AM]Oral Talk #2Global Changes in the Host B cell During the Pre-latent Phase of EBV InfectionPaulina Mrozek-Gorska1, Alexander Buschle1, Antonio Scialdone2, Thomas Schwarzmayr3, Wolfgang Hammerschmidt11Helmholtz Centre Munich Research Unit Gene Vectors, 2Helmholt Centre Munich Institute of Epigenetics and Stem Cells, 3Helmholtz Centre Munich Institute

Session 1: Gene Expression/Epigenetics Read More »

Scroll to Top